It is well known that Ia+ accessory cells are required for presenting antigens to T lymphocytes. This is especially true of CD4+ helper T cells which recognize antigens together with Ia or class II MHC products (1, 2). There is recent evidence that Ia+ dendritic cells directly stimulate CD8+ cytotoxic T cells (3). Since CD4+ cells were not detected in the cultures, and since neither anti-la nor anti-CD4 mAbs blocked dendritic cell function, it appeared that class I molecules on dendritic cells were stimulating CD8 + cells directly (3). Therefore expression of Ia can serve as a marker for active APC (dendritic cells) but may not be required in the presentation of class I MHC products .
CTL Assay. P815 (H-2d), X5563 (H-2 k)
, and YAC-1 (H-2a) cell lines were labeled with Na"Cr04, 10 4 cells were added as targets to graded doses of effector cells in 96-well roundbottomed plates (A/S Nunc) . After 5 h, the plate was centrifuged for 10 min at 400 g and the supernatants were collected to measure released isotope. Spontaneous release was determined in wells without effector cells, and maximal release in wells treated with 0 .1 ml 0 .1 170 Triton X-100 for 30 min before the end of the assay. Percent specific lysis was calculated as : 100 x [(experimental -spontaneous release)/(maximal -spontaneous release)] .
Cyto,Jtuorography. Cells were analyzed (FACStar, B-D Automated Immunochemistry, Salt Lake City, UT), before or after the MLR culture, with FITC-anti-Lyt-2 and PE-anti-L3T4 . Controls were unstained cells . Dead cells were gated out after staining with ethidium bromide . Cell size was monitored by forward light scattering.
To analyze MO in the FAGS, PEC were cultured in Teflon containers for 4 d in the presence or absence of IFN-y . After washing, the cells were incubated with 100 gg/ml human gamma globulin for 30 min at 4°C to block Fc receptors before staining. Lymphocytes were gated out on the basis of their distinct forward and side light scattering properties .
Binding of T Cells to MO . IFN-y treated, TGC-MO (2 x 105) on 13-mm glass coverslips
were treated without or with Nase and cultured with 5-6 x 10 6 T cells in 24-well plates for 2-3 h at 37°C . After washing unbound T cells, the coverslips were fixed with 1 .25% paraformaldehyde for 20 min at room temperature and observed under an inverted phase contrast microscope.
Results
Effect of Nase on the Stimulatory Activity of Macrophages. We previously noted that Ia+, TGC-MO were inactive for stimulating an allogeneic MLR in bulk T cells (6) . This might have been due to an excess of sialic acid on macrophage la antigens, as suggested previously to explain the inactivity of Ia+ B cells (10, 11) . Therefore, we treated rIFN-y+ and rIFN-y -MO with Nase before use as stimulators in the primary MLR . No stimulation was observed in the C3H [H-2k] vs . BALB/c (H-2d) combination (Table I) .
Exogenous IL-2 Synergizes with Nase Treatment to Induce an MLR .
One defect in MO as presenting cells may be an inability to induce the production of T cell growth factors like IL-2 . Therefore, IL-2 was added to the MLR . We also monitored the effects of MO pretreatment with rIFN-y, which upregulates class I and II MHC products ( Fig. 1) , together with Nase (Table I , Fig. 2 A) . HL-2 itself induced T cell proliferation beginning at a dose of 300 U/ml (Fig . 2) . At a lower dose, 30 U/ml, which was just maximal for this preparation in an IL-2 bioassay, IL-2 amplified the MLR in the presence of MO, especially rIFN-y-treated cells (Fig 2 A, Table I ). However, the MO had to have been treated with Nase beforehand and only an allogeneic vs. syngeneic MLR was induced (Table I) . Therefore, Nase pretreatment and exogenous IL-2 together seem to be required for a primary MLR with allogeneic, TGC-MO, while pretreatment with rIFN--t further enhances the response. In The Presence ofIL-2, Nase-treated Macrophages Present Class IMHC. To determine if both class I and II MHC products could be presented by MO, MLRs were set up with select strains including MHC recombinants . In Exp. A, Table II, T cells from A/J mice (kkd) responded to MO from A.TH and CxD2F1, strains that differ at both class I and II MHC loci. A.TL (skd) T cells responded to class I, H-2K-disparate MO (A/J ; kkd), but not class II-disparate MO (A.TH; ssd) . In Exp. B, Table II , A/J (kkd) MO stimulated C3H/He (kkk) that differ at the H-2D class I locus. Exogenous IL-2 was required for these responses to class I (Table II) . On the other hand mixtures of spleen dendritic cells and MO induced strong proliferative responses across all MHC barriers, and exogenous IL-2 was not essential (Table  II) . Because of prior results (3, 9) , stimulation by spleen adherent cells was likely due to the dendritic cell component.
T Cell Subsets that Respond to Nase-treated Macrophages plus IL-2. It is known that CD4+ (Lyt-2 -) and CD8+ (L3T4-) T cells are restricted to antigens presented on MHC class II and I products, respectively (2) . Given the data that Nase-treated MO stimulated across a class I MHC barrier, the MLRs were performed with enriched CD4+ and CD8+ T cells as responders . There were prominent responses by CD8+ T cells as long as the MO were treated with Nase (not shown) and supplemented with low doses of rIL-2 (30 U/ml; Table III Table I . III, Fig. 2 B) . SAC served as a positive control, inducing strong responses in the CD4+ subset . The weak responses of CD4+ T cells to MO was not due to different kinetics of the MLR in this subset (Fig. 3) . Phenotype ofProliferating T Cells by Cytofluorography. During the MLR, the proliferating T cells enlarge and these blasts can be distinguished on the basis of increased forward light scattering. When MO were treated with Nase and used to stimulate CD8+ cells in the presence of IL-2, blasts were detected and these were all stained with anti-CD8 but not anti-CD4 mAb (Fig. 4) . Blasts did not develop in the CD4+ MLR. However, when unseparated T cells were used as the responder population, CD4+ as well as CD8 + blasts were noted (Fig. 4) . Since purified CD4+ cells did not respond to MO, the data indicate that the presence of a CD8 response somehow potentiates the CD4 response.
Development of CTL after Stimulation with Macrophages and IL-2. Since CD8+ cells are the major cytolytic subset in the primary MLR, we evaluated if C3H/He (kkk) T cells formed CTL when stimulated by IFN-,y+ MOB or spleen adherent cells from class 1-disparate A/J (kkd) mice. Lytic cells specific for H-2D vs. H-2K targets did develop. Nase treatment and exogenous IL-2 were required, and only allogeneic T cells formed CTL (Table IV) . The response of enriched CD8+ cells was greater than bulk T cells (Table IV) . With exogenous IL-2, the Nase-treated MO were as effective in inducing CTL as SAC in the absence of IL-2.
Contacts Between Nase-treated Macrophages and T Cells. When dendritic cells stimulate T cells, the two cell types remain in contact for a day or more (12, 13 MOB do not bind T cells (3, 13), but we wondered if Nase-treated cells did. This proved to be the case (Fig. 5) . Both CD4+ and CD8+ T cells bound to Nase-treated MOB. If the nonadherent T cells were removed, some of the attached CD8' T cells later proliferated, but the CD4' did not (9,091 vs. 385 cpm, respectively). Nase and Exogenous IL-2 Effects on MLR Stimulation by FreshM0 2-h adherent, TGCelicited PEC were used to stimulate the MLR in bulk T cells and in enriched CD4' and CD8' subsets. In some cases, the PEC were treated with anti-Ia and complement to remove a subset of 3-8°Io Ia' PEC . Very weak MLRs were observed with all populations of T cells, and Ia' cell depletion abolished the weak CD4' MLR (Table V) . However, if either Nase treatment or exogenous rIL-2 was included, an MLR occurred, but primarily in the CD8' subset (Table V) . When the same MO were cultured for 4 d, it was again necessary to expose them to IFN -y, treat them with Nase, and add IL-2 to observe sizable MLRs (Table V) .
Effect of Nase and Exogenous IL-2 on B Cell-stimulated MLRs. Like MO, small B cells are inactive as MLR stimulators (10, (13) (14) (15) . To determine if B cells could be rendered immunogenic in a manner comparable to MO, the lymphocytes were treated with Nase and added to allogeneic CD8' or CD4' T cells plus or minus exogenous IL-2. The results were comparable to the MO findings . Both Nase and IL-2 were required to observe an allogeneic MLR with foreign B cells, and only the CD8' subset responded directly (Table VI) . Discussion A considerable amount ofliterature has shown that lymphoid dendritic cells (isolated from lymphoid organs, blood, and lymph) actively stimulate an MLR. In the mouse it has been shown that class I and II MHC products are presented (9) and that purified CD4' and CD8' subsets respond (3). In contrast, most populations of MO and B lymphocytes, when depleted of dendritic cells, are weak stimulator . Blastogenesis of CD8`T cells stimulated by Nase-treated, IFN-y+ Mo in the presence of exogenous rIL-2. CD8', CD4*, and bulk cells from CxD2F) mice were stained with anti-CD8 or anti-CD4 mAbs before culture (top panels). The subsets were cultured with 100 U/ml rIL-2 without or with Nase-treated MO from C3H mice for 85 h. At the end of culture, cells were collected, washed, stained with anti-CD8 and anti-CD4 antibodies, and analyzed by FACStar. Cell size was monitored by forward light scattering . cells across either MAC barrier and with either T cell subset as responders (3, 9) . The lack of stimulation by MO does not seem to be due to a suppressive activity. While MO can suppress the MLR that is induced by dendritic cells, we have shown that appropriate doses of MO actually enhance the MLR at very low doses of dendritic cells (6) . Also, MO present both class I (3) and II (8, 13) MHC products to sensitized CD8+ and CD4 + lymphoblasts . Here we have succeeded in making MO directly immunogenic, that is in the apparent absence of dendritic cells. The variables that were studied were pretreatment of the MO with rIFN-y and with Nase, and the supplementation f the MLR with exogenous IL-2.
Lymphokines, especially rIFN-y, have a marked effect on the expression of class II MHC products on inflammatory MO. When cultured in the absence oflymphokine, the levels of la become undetectable on most cells, while in its presence, la is found on most MO (4, 16) (Fig . 1) . Lymphokines also upregulate class I MHC products, although the latter are expressed constitutively (4, 17) (Fig. 1) . In our studies, rIFN-y + MO were more active as stimulators, but IFN-y-cells had some activity (Tables I, III , and IV). Our experiments do not permit us to determine if the effect of rIFN-y is due to a greater expression of class I products or to some other variable, such as production of an amplifying cytokine .
Mm treatment with Nase was essential for observing stimulation in the MLR (Tables I and III; Fig. 2 ). In contrast, no enhancement of MLR was observed when responder T cells or stimulator dendritic cells were treated with Nase (not shown) . Addition of the Nase inhibitor (2,3-dehydro-2-deoxy-N-acethy-neuraminic acid, 2 mg/ml; Boehringer Mannheim Biochemicals, Indianapolis, IN) during the treatment of MO with Nase abrogated its enhancing effect on the MLR, while incuba- tion of Nase-treated MO with Nase-inhibitor did not abolish stimulatory activity (not shown) . Therefore, it seems unlikely that the effects we observed were due to Nase carryover. The use of Nase was suggested by the work of Cowing and colleagues, who found that Nase enhanced stimulation by enriched populations of B cells (10, 11) . They suggested that Nase acted by reducing the amount of sialic acid on class II MHC products, but it is possible that Nase modification of other molecules allows the presenting cell and T cell to contact each other (Fig . 5) . Native B cells and MO do not seem to form such contacts (3, 13, 18) . It has been reasoned that one of the rate- limiting steps in the MLR is the capacity of the allogeneic stimulator cell to form stable conjugates with the responding T cell (13, 19) . To date, lymphoid dendritic cells are the principal cell type that can form such clusters in antigen-dependent primary responses .
Clustering, however, does not seem sufficient for immunogenicity. Nase-treated MO and small B cells still required exogenous IL-2 . By inference, then, one of the distinguishing features of dendritic cells and MO as APC is that dendritic cells seem capable of inducing the endogenous production of essential growth factors.
Together, the combined treatment with IFN-y, Nase, and IL-2 only renders the MCP immunogenic for the CD8' subset . Resting CD4' T cells do not respond class II-disparate MO (Table III) , whereas the number of enlarged blasts in the CD8+ MLR was considerable (Fig. 4) . This might indicate that CD8' cells differ in the presenting cell requirements for the appearance ofthe IL-2-responsive state. In contrast, dendritic cells actively stimulate a state of IL-2 responsiveness in CD4' lymphocytes (13) .
Although we were unable to triggr the CD4 + subset directly with MO, our studies provide preliminary information that it may be possible to do so. Specificially, we noted the development of CD4+ T blasts when the responding population contained both CD8' and CD4+ T cells (Fig. 4) . One possibility is that MO synthesize amplifying factors like IL-1 or IL-6, but that these factors are only released after the development of CD8`CTL (Table IV) , thus liberating cell-associated activating factors for use by other MO.
Summary
Prior work has shown that purified, resident, and inflammatory peritoneal macrophages are weak stimulators of the allogeneic MLR . We have identified conditions whereby thioglycollate-elicited macrophages become stimulatory, but primarily for the CD8+ T cell subset . The conditions were to treat the macrophages with neuraminidase and to supplement the MLR with rIL-2 . These treatments together led to proliferative and cytotoxic responses by isolated CD8+ but not CD4' T cells . Likewise when MHC-congenic strains were evaluated, an MLR was observed across isolated class I but not class II MHC barriers . Pretreatment of the macrophages with IFN-y further enhanced expression of class I MHC products and stimulatory activity, but did not seem essential. While these treatments did not render macrophages stimulatory for an MLR in purified CD4+ cells, blastogenesis of CD4+ cells was observed when the MLR involved bulk T cells. Small allogeneic B lymphocytes behaved similarly to macrophages, in that pretreatment with neuraminidase and supplementation with rIL-2 rendered B cells stimulatory for allogeneic, enriched, CD8', but not CD4', T cells. Spleen adherent cells, which are mixtures of macrophages and dendritic cells, stimulated both CD4 + and CD8+ T cells, and neither neuraminidase nor exogenous IL-2 was required . We think that these data suggest that most macrophages and small B cells lack three important functions ofdendritic cells : a T cell-binding function that can be remedied by neuraminidase treatment, a T cell growth factor-inducing function that can be bypassed with exogenous IL-2, and an IL-2 responsiveness function that is required by CD4' lymphocytes .
